测试塔达拉菲尔的认知效应. 来自PASTIS试验的神经心理二次结果
Mathilde Mh Pauls1,2, Jessica Fish3,4, Lauren R Binnie1
1Molecular & Clinical Sciences Research Institute, St George's University of London, UK.
Cerebral circulation - cognition and behavior
|October 9, 2023
概括
单剂量塔达拉菲尔在患有脑小血管疾病 (SVD) 的老年人中没有显著改善认知功能. 观察到改善短期记忆的潜在趋势,需要在未来的临床试验中进一步调查.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 老年学是一门学科.
背景情况:
- 大脑小血管疾病 (SVD) 是导致老年人认知能力下降的主要原因.
- 固酶5型 (PDE5) 抑制剂,如塔达拉菲尔,是广泛使用的药物.
- 了解SVD相关认知障碍的干预措施对于老龄化人口至关重要.
研究的目的:
- 评估单剂量塔达拉菲尔对被诊断患有SVD的老年人认知表现的疗效.
- 评估塔达拉菲尔对各种认知领域的影响,包括注意力,处理速度,工作记忆和执行功能.
主要方法:
- 进行了一项双盲,安慰剂控制,交叉临床试验.
- 参与者接受一次20毫克的塔达拉菲尔剂量或安慰剂,在至少7天间隔的单独访问中进行治疗.
- 用蒙特利尔认知评估 (MOCA) 和治疗前后的一系列神经心理测试来评估认知功能.
主要成果:
- 在任何神经心理测试中,在服用塔达拉菲尔后没有观察到统计学上显著的改善.
- 在 Digit Span Forward 测试中,发现了一种非显著的增强性能的趋势 (p=0.0521).
- 该研究包括55名参与者 (平均年龄66.8岁),平均MOCA分数为26.
结论:
- 单剂量塔达拉菲尔在患有SVD的老年人中没有显示出显著的认知益处.
- 观察到的短期记忆的趋势需要进一步的研究,以探索潜在的治疗效果.
- 未来的研究应该调查PDE5抑制剂在SVD中的最佳剂量和长期影响.
相关概念视频
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
169
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
169
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
136
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
136
01:22Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
01:54The Placebo Effect
6.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.2K
01:30Cognitive Development During Adulthood
129
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
129